The role of cell adhesion molecule in cancer progression and its application in cancer therapy.

Multiple and diverse cell adhesion molecules take part in intercellular and cell-extracellular matrix interactions of cancer. Cancer progression is a multi-step process in which some adhesion molecules play a pivotal role in the development of recurrent, invasive, and distant metastasis. A growing body of evidence indicates that alterations in the adhesion properties of neoplastic cells play a pivotal role in the development and progression of cancer. Loss of intercellular adhesion and the desquamation of cells from the underlying lamina propria allows malignant cells to escape from their site of origin, degrade the extracellular matrix, acquire a more motile and invasion phenotype, and finally, invade and metastasize. In addition to participating in tumor invasiveness and metastasis, adhesion molecules regulate or significantly contribute to a variety of functions including signal transduction, cell growth, differentiation, site-specific gene expression, morphogenesis, immunologic function, cell motility, wound healing, and inflammation. Cell adhesion molecule (CAM), a diverse system of transmembrane glycoproteins has been identified that mediates the cell-cell and cell-extracellular matrix adhesion and also serves as the receptor for different kinds of virus. We summarize recent progress regarding the role of CAM, particularly, immunoglobulin-CAMs and cadherins in the progression of cancer and discuss the potential application of CAMs in the development of cancer therapy mainly on urogenital cancer.

[1]  L. Philipson,et al.  HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Dummer,et al.  The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. , 1998, Human gene therapy.

[3]  B. Vogelstein,et al.  Cell adhesion molecules as tumour suppressors. , 1993, Trends in cell biology.

[4]  J. Tomaszewski,et al.  Novel p21WAF1/CIP1 mutations in superficial and invasive transitional cell carcinomas. , 1996, Oncogene.

[5]  R. Hazan,et al.  N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. , 1997, Cell adhesion and communication.

[6]  R. Kemler,et al.  The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. , 1989, The EMBO journal.

[7]  M. Arenas,et al.  E-, N- And P-cadherin, and α-, β- and γ-catenin Protein Expression in Normal, Hyperplastic and Carcinomatous Human Prostate , 2000, The Histochemical Journal.

[8]  B. Obrink,et al.  Intercellular adhesion of rat hepatocytes. Identification of a cell surface glycoprotein involved in the initial adhesion process. , 1982, The Journal of biological chemistry.

[9]  N. Beauchemin,et al.  The expression of mouse biliary glycoprotein, a carcinoembryonic antigen-related gene, is down-regulated in malignant mouse tissues. , 1993, Cancer research.

[10]  J. Bergelson,et al.  The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Hsieh,et al.  Induction of apoptosis and G2/M cell cycle arrest by DCC , 1999, Oncogene.

[12]  D. Curiel,et al.  Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression. , 2003, Cancer research.

[13]  W. H. Porter,et al.  Soluble forms of the adhesion molecule E-cadherin in urine. , 1995, Journal of clinical pathology.

[14]  W. Birchmeier,et al.  Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion , 1989, The Journal of cell biology.

[15]  J. Zabner,et al.  Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. , 1997, The Journal of clinical investigation.

[16]  T. Fojo,et al.  Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228. , 2001, Cancer research.

[17]  M. Takeichi,et al.  Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.

[18]  A. Nose,et al.  Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. II. Skin morphogenesis. , 1989, Development.

[19]  Kathleen R. Cho,et al.  The DCC gene product in cellular differentiation and colorectal tumorigenesis. , 1994, Genes & development.

[20]  C. Ahn,et al.  Differential effects of adenovirus-p16 on bladder cancer cell lines can be overcome by the addition of butyrate. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  L. Duan,et al.  Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  J. Schalken,et al.  Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. , 1996, Cancer research.

[23]  C. Miller,et al.  Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. , 1998, Cancer Research.

[24]  M. Takeichi,et al.  Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. , 1987, Developmental biology.

[25]  E. Kovacs,et al.  E-cadherin Homophilic Ligation Directly Signals through Rac and Phosphatidylinositol 3-Kinase to Regulate Adhesive Contacts* , 2002, The Journal of Biological Chemistry.

[26]  T. P. Pretlow,et al.  Expression of E-cadherin in primary and metastatic prostate cancer. , 1996, The American journal of pathology.

[27]  H. Salazar,et al.  Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. , 1997, Human pathology.

[28]  P. Walsh,et al.  Clinical and experimental studies of benign prostatic hyperplasia. , 1990, The Urologic clinics of North America.

[29]  J. Bergelson,et al.  The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. , 2000, Cancer research.

[30]  Y. Jan,et al.  frazzled Encodes a Drosophila Member of the DCC Immunoglobulin Subfamily and Is Required for CNS and Motor Axon Guidance , 1996, Cell.

[31]  T. Shuin,et al.  Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer. , 1996, The Journal of urology.

[32]  J. Daniel,et al.  Tyrosine phosphorylation and cadherin/catenin function , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[33]  A. Sagalowsky,et al.  Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. , 1999, Cancer research.

[34]  M. Jaurand,et al.  The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. , 1995, Human pathology.

[35]  W. Isaacs,et al.  P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  W. Birchmeier,et al.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells , 1991, The Journal of cell biology.

[37]  W. Birchmeier,et al.  Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. , 1994, Biochimica et biophysica acta.

[38]  C. Dinney,et al.  Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. , 1996, Cancer research.

[39]  S. H. Lin,et al.  Differential expression of C-CAM cell adhesion molecule in prostate carcinogenesis in a transgenic mouse model. , 1999, The Journal of urology.

[40]  A. P. Soler,et al.  Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology. , 1997, The American journal of pathology.

[41]  J. Herman,et al.  E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. , 1995, Cancer research.

[42]  M. Emi,et al.  Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers , 1996, Genes, chromosomes & cancer.

[43]  M. Cohen,et al.  Cellular adhesion molecules in urologic malignancies. , 1997, American journal of clinical pathology.

[44]  A. Nose,et al.  Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis , 2005 .

[45]  S. H. Lin,et al.  Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATPase. The primary structure of the ecto-ATPase is similar to that of the human biliary glycoprotein I. , 1989, The Journal of biological chemistry.

[46]  J. Bergelson,et al.  Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5 , 1997, Science.

[47]  J. Marshall,et al.  A phase I trial of depsipeptide (FR901228) in patients with advanced cancer. , 2002, Journal of experimental therapeutics & oncology.

[48]  A. Sagalowsky,et al.  The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure. , 2001, Cancer research.

[49]  E. Gelmann,et al.  Alterations in β-Catenin Phosphorylation and Plakoglobin Expression in Human Breast Cancer Cells , 1994 .

[50]  S. H. Lin,et al.  Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. , 1995, Cancer research.

[51]  N. Konishi,et al.  E-cadherin and α-, β- and γ-catenin expression in prostate cancers: correlation with tumour invasion , 1999, British Journal of Cancer.

[52]  E. Fearon,et al.  DCC: linking tumor suppressor genes and altered cell surface interactions in cancer? , 1995, Current opinion in genetics & development.

[53]  A. Lucas,et al.  Comparative transductions of breast cancer cells by three DNA viruses. , 2003, Biochemical and biophysical research communications.

[54]  E. Gelmann,et al.  Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. , 1994, Cancer research.

[55]  H. Bonkhoff,et al.  Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model , 1996, The Prostate.

[56]  W. Isaacs,et al.  Reduction of E-Cadherin Levels and Deletion of the α-Catenin Gene in Human Prostate Cancer Cells , 1993 .

[57]  J. McPherson,et al.  Assignment of the human alpha-catenin gene (CTNNA1) to chromosome 5q21-q22. , 1994, Genomics.

[58]  M. Neumaier,et al.  Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[59]  S. Brewster,et al.  Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. , 1994, British Journal of Cancer.

[60]  Sue-Hwa Lin,et al.  Signal Transduction by the CEACAM1 Tumor Suppressor , 2001, The Journal of Biological Chemistry.

[61]  A. D. De Marzo,et al.  Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer. , 2002, Urology.

[62]  S. Cusack,et al.  Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 A resolution. , 2000, Structure.

[63]  Yan Wang,et al.  Structural analysis of the C‐CAM1 molecule for its tumor suppression function in human prostate cancer , 1999, The Prostate.

[64]  S. H. Lin,et al.  Androgen regulation of cell adhesion molecule gene expression in rat prostate during organ degeneration. C-CAM belongs to a class of androgen-repressed genes associated with enriched stem/amplifying cell population after prolonged castration. , 1994, The Journal of biological chemistry.

[65]  W. Arthur,et al.  Cadherin Engagement Inhibits RhoA via p190RhoGAP* , 2003, The Journal of Biological Chemistry.

[66]  T. Liu,et al.  Inhibition of Prostate Tumor Angiogenesis by the Tumor Suppressor CEACAM1* , 2002, The Journal of Biological Chemistry.

[67]  S. Hirohashi,et al.  Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. , 1989, Cancer research.

[68]  《中华放射肿瘤学杂志》编辑部.  Medline , 2001, Current Biology.

[69]  K. Nakagawa,et al.  Soluble E-cadherin fragments increased in circulation of cancer patients. , 1994, British Journal of Cancer.

[70]  Gerhard Christofori,et al.  Cell adhesion and signalling by cadherins and Ig-CAMs in cancer , 2004, Nature Reviews Cancer.

[71]  W. Isaacs,et al.  Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function. , 1995, Cancer research.

[72]  J. Schalken,et al.  Decreased expression of E-cadherin in the progression of rat prostatic cancer. , 1992, Cancer research.

[73]  C. Daniel,et al.  Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. , 1995, Developmental biology.

[74]  R. Weinberg,et al.  Phenotype of mice lacking functional Deleted in colorectal cancer (Dec) gene , 1997, Nature.

[75]  Thomas,et al.  Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. , 1995, Cancer research.

[76]  B. Gumbiner,et al.  Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin , 2003, The Journal of cell biology.

[77]  D. Neal,et al.  Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence. , 1996, British Journal of Cancer.

[78]  M. Arenas,et al.  E-, N- and P-cadherin, and alpha-, beta- and gamma-catenin protein expression in normal, hyperplastic and carcinomatous human prostate. , 2000, The Histochemical journal.

[79]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[80]  Sue-Hwa Lin,et al.  Association of an 80  kDa protein with C-CAM1 cytoplasmic domain correlates with C-CAM1-mediated growth inhibition , 1998, Oncogene.

[81]  J. McPherson,et al.  Assignment of the Human α-Catenin Gene (CTNNA1) to Chromosome 5q21-q22 , 1994 .

[82]  W. Isaacs,et al.  Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. , 1993, Cancer research.

[83]  S. H. Lin,et al.  Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study. , 1995, Cancer research.

[84]  B. Obrink,et al.  Alterations in the expression of a hepatocyte cell adhesion molecule by transplantable rat hepatocellular carcinomas. , 1985, Cancer research.

[85]  K. Chew,et al.  Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. , 2002, Cancer research.

[86]  M. Sachs,et al.  Integrin αv and coxsackie adenovirus receptor expression in clinical bladder cancer , 2002 .

[87]  I. Sardi,et al.  Molecular alterations of E-cadherin gene: possible role in human bladder carcinogenesis. , 2000, International journal of molecular medicine.

[88]  W. Nelson,et al.  Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. , 1995, Proceedings of the National Academy of Sciences of the United States of America.